{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:08:50Z","timestamp":1793711330281,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T00:00:00Z","timestamp":1594425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T00:00:00Z","timestamp":1594425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81801379"],"award-info":[{"award-number":["81801379"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011488","name":"Health and Family Planning Committee of Pudong New Area","doi-asserted-by":"publisher","award":["PWYgf2018-02"],"award-info":[{"award-number":["PWYgf2018-02"]}],"id":[{"id":"10.13039\/501100011488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008410","name":"Shanghai Municipal Population and Family Planning Commission","doi-asserted-by":"publisher","award":["201840112"],"award-info":[{"award-number":["201840112"]}],"id":[{"id":"10.13039\/501100008410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["22120180600"],"award-info":[{"award-number":["22120180600"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coronary artery ectasia (CAE) is an angiographic finding of abnormal coronary dilatation. Inflammation plays a major role in all phases of atherosclerosis. We investigated the relationship between CAE and serum high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6) levels to test our hypothesis that patient age is associated with the efficacy of anti-inflammatory therapy for CAE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a prospective analysis of 217 patients with CAE treated at the Department of Cardiology, Shanghai East Hospital, Ji\u2019an Campus and the Baoshan People\u2019s Hospital, from January 1, 2015 to July 30, 2019. Baseline data of patients, including sex; age; and history of hypertension, hyperlipidemia, and diabetes, were collected from patient medical records. Study participants were grouped by age as follows: CAE-A (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u200960, age\u2009\u2264\u200950\u2009years), CAE-B (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u200983, 50\u2009years &lt;age\u2009\u2264\u200970\u2009years), and CAE-C (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u200974, age\u2009&gt;\u200970). Additionally, there was a control (NC) group (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u200973) with normal coronary arteries.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All patients received oral rosuvastatin therapy (10\u2009mg, QN quaque nocte) when they were diagnosed with CAE and maintained good follow-up, with a loss rate of 0.0% at the end of the 6-month follow-up. The NC group received regular symptom-relieving treatments and rosuvastatin therapy. Of these four groups, the inflammatory markers, hs-CRP and IL-6, were significantly higher in patients with CAE than in the NCs (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.05). Post-hoc tests showed that hs-CRP and Il-6 levels had significant differences between the CAE-A and CAE-C groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.048,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.025). Logistic regression analysis showed that hs-CRP (OR\u2009=\u20091.782, 95% CI: 1.124\u20132.014,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.021) and IL-6 (OR\u2009=\u20091.584, 95% CI: 1.112\u20131.986,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.030) were independent predictors of CAE. The inflammatory markers were higher in the CAE-A group than in the CAE-B group and higher in the CAE-B group than in the CAE-C group. Follow-up after 6\u2009months of rosuvastatin therapy showed a significantly greater reduction in hs-CRP and IL-6 levels in the CAE-A group than in the CAE-B group, which again were greater in the CAE-B group than in the CAE-C group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Anti-inflammatory therapy using rosuvastatin was more effective in younger CAE patients, indicating the need for early statin therapy in CAE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-020-01604-z","type":"journal-article","created":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T00:52:57Z","timestamp":1594428777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Anti-inflammatory effects of rosuvastatin treatment on coronary artery ectasia patients of different age groups"],"prefix":"10.1186","volume":"20","author":[{"given":"Cheng-Hui","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8926-6918","authenticated-orcid":false,"given":"Yu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,11]]},"reference":[{"key":"1604_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1136\/hrt.54.4.392","volume":"54","author":"GG Hartnell","year":"1985","unstructured":"Hartnell GG, Parnell BM, Pridie RB. Coronary artery ectasia. Its prevalence and clinical significance in 4993 patients. Heart. 1985;54:392\u20135.","journal-title":"Heart"},{"key":"1604_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1055\/s-0039-1688467","volume":"7","author":"D Carino","year":"2019","unstructured":"Carino D, Agarwal A, Singh M, Meadows J, Ziganshin BA, Elefteriades JA. Coronary aneurysm: an enigma wrapped in a mystery. Aorta (Stamford). 2019;7:71\u20134.","journal-title":"Aorta (Stamford)"},{"key":"1604_CR3","first-page":"e4876","volume":"11","author":"V Tandon","year":"2019","unstructured":"Tandon V, Tandon AA, Kumar M, Mosebach CM, Balakumaran K. Coronary artery aneurysms: analysis of comorbidities from the national inpatient sample. Cureus. 2019;11:e4876.","journal-title":"Cureus."},{"key":"1604_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.carpath.2018.04.005","volume":"35","author":"S Ozturk","year":"2018","unstructured":"Ozturk S, Yetkin E, Waltenberger J. Molecular and cellular insights into the pathogenesis of coronary artery ectasia. Cardiovasc Pathol. 2018;35:37\u201347.","journal-title":"Cardiovasc Pathol"},{"key":"1604_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.14744\/AnatolJCardiol.2017.7738","volume":"17","author":"F Kahraman","year":"2017","unstructured":"Kahraman F, Karabacak M, T\u00fcrker Y. Serum nitric oxide level in patients with coronary artery ectasia. Anatol J Cardiol. 2017;17:341.","journal-title":"Anatol J Cardiol"},{"key":"1604_CR6","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1161\/01.CIR.91.5.1375","volume":"91","author":"K Sudhir","year":"1995","unstructured":"Sudhir K, Ports TA, Amidon TM, Goldberger JJ, Bhushan V, Kane JP, et al. Increased prevalence of coronary ectasia in heterozygous familial hypercholesterolemia. Circulation. 1995;91:1375\u201380.","journal-title":"Circulation."},{"key":"1604_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint National Committee (JNC 8). JAMA. 2014;311:507\u201320.","journal-title":"JAMA."},{"key":"1604_CR8","first-page":"9","volume":"18","author":"L Liu","year":"2020","unstructured":"Liu L, Huang C, Liao W, Chen S, Cai S. Smoking behavior and smoking index as prognostic indicators for patients with esophageal squamous cell carcinoma who underwent surgery: a large cohort study in Guangzhou, China. Tob Induc Dis. 2020;18:9.","journal-title":"Tob Induc Dis"},{"key":"1604_CR9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1177\/0003319716665690","volume":"68","author":"Y Luo","year":"2017","unstructured":"Luo Y, Tang J, Liu X, Qiu J, Ye Z, Lai Y, et al. Coronary artery aneurysm differs from coronary artery ectasia: angiographic characteristics and cardiovascular risk factor analysis in patients referred for coronary angiography. Angiology. 2017;68:823\u201330.","journal-title":"Angiology."},{"key":"1604_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.bcp.2007.07.004","volume":"75","author":"JD Raffetto","year":"2008","unstructured":"Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol. 2008;75:346\u201359.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1604_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/CRD.0000000000000176","volume":"26","author":"B Tun","year":"2018","unstructured":"Tun B, Frishman WH. Effects of anti-inflammatory medications in patients with coronary artery disease: a focus on Losmapimod. Cardiol Rev. 2018;26(3):152\u20136.","journal-title":"Cardiol Rev"},{"key":"1604_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.neuroscience.2014.10.014","volume":"284","author":"FB Seker","year":"2015","unstructured":"Seker FB, Kilic U, Caglayan B, Ethemoglu MS, Caglayan AB, Ekimci N, et al. HMG-CoA reductase inhibitor rosuvastatin improves abnormal brain electrical activity via mechanisms involving eNOS. Neuroscience. 2015;284:349\u201359.","journal-title":"Neuroscience."},{"key":"1604_CR13","doi-asserted-by":"publisher","first-page":"E813","DOI":"10.1152\/ajpendo.00266.2004","volume":"288","author":"S Kim","year":"2005","unstructured":"Kim S, Kim CH, Vaziri ND. Upregulation of hepatic LDL receptor-related protein in nephrotic syndrome: response to statin therapy. Am J Physiol Endocrinol Metab. 2005;288:E813\u20137.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1604_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jpeds.2019.07.064","volume":"215","author":"AH Tremoulet","year":"2019","unstructured":"Tremoulet AH, Jain S, Jone P-N, Best BM, Duxbury EH, Franco A, et al. Phase I\/IIa trial of atorvastatin in patients with acute kawasaki disease with coronary artery aneurysm. J Pediatrics. 2019;215:107\u201317.e12.","journal-title":"J Pediatrics"},{"key":"1604_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.atherosclerosis.2005.04.016","volume":"184","author":"J Chen","year":"2006","unstructured":"Chen J, Li D, Schaefer R, Mehta JL. Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan. Atherosclerosis. 2006;184:295\u2013301.","journal-title":"Atherosclerosis."},{"key":"1604_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.atherosclerosis.2016.02.028","volume":"248","author":"Z Li","year":"2016","unstructured":"Li Z, Wang L, Hu X, Zhang P, Chen Y, Liu X, et al. Effect of rosuvastatin on atherosclerotic plaque stability: an intravascular ultrasound elastography study. Atherosclerosis. 2016;248:27\u201335.","journal-title":"Atherosclerosis."},{"key":"1604_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.4330\/wjc.v8.i5.351","volume":"8","author":"G Dendramis","year":"2016","unstructured":"Dendramis G, Paleologo C, Piraino D, Assennato P. Relationship between coronary artery ectasia, cocaine abuse and acute coronary syndromes. World J Cardiol. 2016;8:351\u20135.","journal-title":"World J Cardiol"},{"key":"1604_CR18","doi-asserted-by":"publisher","first-page":"824","DOI":"10.29271\/jcpsp.2018.11.824","volume":"28","author":"S Rashid","year":"2018","unstructured":"Rashid S, Gul U, Ali M, Sadiq T, Mehmood KA. Coronary artery ectasia: clinical and angiographic features. J Coll Physicians Surg Pak. 2018;28:824\u20138.","journal-title":"J Coll Physicians Surg Pak"},{"key":"1604_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/MAJ.0000000000000292","volume":"348","author":"CM Gamboa","year":"2014","unstructured":"Gamboa CM, Safford MM, Levitan EB, Mann DM, Yun H, Glasser SP, et al. Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart disease. Am J Med Sci. 2014;348:108\u201314.","journal-title":"Am J Med Sci"},{"key":"1604_CR20","doi-asserted-by":"crossref","unstructured":"CASS Principal Investigators and their Associates. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery: survival data. 1983;68(5):939\u201350.","DOI":"10.1161\/01.CIR.68.5.939"},{"key":"1604_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","volume":"34","author":"JR Petrie","year":"2018","unstructured":"Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34:575\u201384.","journal-title":"Can J Cardiol"},{"key":"1604_CR22","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.2174\/0929867321666131227162950","volume":"21","author":"M-J van Rooy","year":"2014","unstructured":"van Rooy M-J, Pretorius E. Obesity, hypertension and hypercholesterolemia as risk factors for atherosclerosis leading to ischemic events. Curr Med Chem. 2014;21:2121\u20139.","journal-title":"Curr Med Chem"},{"key":"1604_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cyto.2018.11.015","volume":"115","author":"T Uygun","year":"2019","unstructured":"Uygun T, Demir B, Tosun V, Ungan \u0130, Kural A, \u00c7ift\u00e7i R, et al. Relationship between interleukin-17A and isolated coronary ectasia. Cytokine. 2019;115:84\u20138.","journal-title":"Cytokine."},{"key":"1604_CR24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.33963\/KP.14812","volume":"77","author":"S Iwa\u0144czyk","year":"2019","unstructured":"Iwa\u0144czyk S, Borger M, Kami\u0144ski M, Chmara E, Cie\u015blewicz A, Tykarski A, et al. Inflammatory response in patients with coronary artery ectasia and coronary artery disease. Kardiol Pol. 2019;77:713\u20135.","journal-title":"Kardiol Pol"},{"key":"1604_CR25","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1093\/eurheartj\/ehl208","volume":"27","author":"S Monte","year":"2006","unstructured":"Monte S, Macchia A, Pellegrini F, Romero M, Lepore V, D'Ettorre A, et al. Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation. Eur Heart J. 2006;27:2217\u201323.","journal-title":"Eur Heart J"},{"key":"1604_CR26","doi-asserted-by":"publisher","first-page":"939","DOI":"10.12659\/AJCR.900474","volume":"17","author":"T Tomioka","year":"2016","unstructured":"Tomioka T, Takeuchi S, Ito Y, Shioiri H, Koyama J, Inoue K. Recurrent acute myocardial infarction in a patient with severe coronary artery ectasia: implication of antithrombotic therapy. Am J Case Rep. 2016;17:939\u201343.","journal-title":"Am J Case Rep"},{"key":"1604_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/1755-5922.12106","volume":"33","author":"A Dahhan","year":"2015","unstructured":"Dahhan A. Coronary artery ectasia in atherosclerotic coronary artery disease, inflammatory disorders, and sickle cell disease. Cardiovasc Ther. 2015;33:79\u201388. https:\/\/doi.org\/10.1111\/1755-5922.12106.","journal-title":"Cardiovasc Ther"},{"key":"1604_CR28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.5152\/akd.2011.076","volume":"11","author":"T Aksu","year":"2011","unstructured":"Aksu T, Uygur B, Kosar MD, Guray U, Arat N, Korkmaz S, Colak A. Coronary artery ectasia: its frequency and relationship with atherosclerotic risk factors in patients undergoing cardiac catheterization. Anadolu Kardiyol Dergisi\/Anatol J Cardiol. 2011;11:280\u20135. https:\/\/doi.org\/10.5152\/akd.2011.076.","journal-title":"Anadolu Kardiyol Dergisi\/Anatol J Cardiol"},{"key":"1604_CR29","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.atherosclerosis.2014.01.018","volume":"233","author":"ND Brunetti","year":"2014","unstructured":"Brunetti ND, Salvemini G, Cuculo A, Ruggiero A, De Gennaro L, Gaglione A, et al. Coronary artery ectasia is related to coronary slow flow and inflammatory activation. Atherosclerosis. 2014;233:636\u201340.","journal-title":"Atherosclerosis."},{"key":"1604_CR30","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2143\/AC.59.5.2005226","volume":"59","author":"L Tokgozoglu","year":"2004","unstructured":"Tokgozoglu L, Ergene O, Kinay O, Nazli C, Hascelik G, Hoscan Y. Plasma interleukin-6 levels are increased in coronary artery ectasia. Acta Cardiol. 2004;59:515\u20139.","journal-title":"Acta Cardiol"},{"key":"1604_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1055\/s-0039-1692706","volume":"28","author":"R Pranata","year":"2019","unstructured":"Pranata R, Yonas E, Chintya V, Alkatiri AA. Is anticoagulant necessary in patients with coronary artery ectasia presenting with acute coronary syndrome? A systematic review of case reports. Int J Angiol. 2019;28:231\u20136.","journal-title":"Int J Angiol"},{"key":"1604_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12872-020-01398-0","volume":"20","author":"Y Guo","year":"2020","unstructured":"Guo Y, Liu R, Chen L, Wu W, Zhang S. Neutrophil activation and neutrophil derived neutrophil extracellular trap formation in patients with coronary artery ectasia. BMC Cardiovasc Disord. 2020;20:101.","journal-title":"BMC Cardiovasc Disord"},{"key":"1604_CR33","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1177\/0300060516664637","volume":"44","author":"M Y\u0131lmaz","year":"2016","unstructured":"Y\u0131lmaz M, Korkmaz H, Bilen MN, Uku \u00d6, Kurto\u011flu E. Could neutrophil\/lymphocyte ratio be an indicator of coronary artery disease, coronary artery ectasia and coronary slow flow? J Int Med Res. 2016;44:1443\u201353.","journal-title":"J Int Med Res"},{"issue":"4","key":"1604_CR34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.5603\/KP.a2013.0349","volume":"72","author":"E Kalayc\u0131o\u011flu","year":"2014","unstructured":"Kalayc\u0131o\u011flu E, G\u00f6kdeniz T, Aykan AC, et al. Comparison of neutrophil to lymphocyte ratio in patients with coronary artery ectasia versus patients with obstructive coronary artery disease. Kardiol Pol. 2014;72(4):372\u201380. https:\/\/doi.org\/10.5603\/KP.a2013.0349.","journal-title":"Kardiol Pol"},{"key":"1604_CR35","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/0003319713480424","volume":"64","author":"S Balta","year":"2013","unstructured":"Balta S, Demirkol S, Celik T, Kucuk U, Unlu M, Arslan Z, et al. Association between coronary artery ectasia and neutrophil\u2013lymphocyte ratio. Angiology. 2013;64:627\u201332.","journal-title":"Angiology."},{"key":"1604_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cyto.2008.12.012","volume":"46","author":"JJ Li","year":"2009","unstructured":"Li JJ, Nie SP, Qian XW, Zeng HS, Zhang CY. Chronic inflammatory status in patients with coronary artery ectasia. Cytokine. 2009;46:61\u20134.","journal-title":"Cytokine."},{"key":"1604_CR37","first-page":"833","volume":"129","author":"U Boles","year":"2019","unstructured":"Boles U, Wiklund U, David S, Ahmed K, Henein MY. Coronary artery ectasia carries worse prognosis: a long-term follow-up study. Pol Arch Intern Med. 2019;129:833\u20135.","journal-title":"Pol Arch Intern Med"},{"key":"1604_CR38","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1111\/bph.13805","volume":"174","author":"AL Catapano","year":"2017","unstructured":"Catapano AL, Pirillo A, Norata GD. Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trials. Br J Pharmacol. 2017;174:3973\u201385.","journal-title":"Br J Pharmacol"},{"key":"1604_CR39","doi-asserted-by":"publisher","first-page":"E79","DOI":"10.3390\/biomedicines7040079","volume":"7","author":"J Jafari","year":"2019","unstructured":"Jafari J, Daum A, Hamed JA, Osherov A, Orlov Y, Yosefy C, et al. Low high-density lipoprotein cholesterol predisposes to coronary artery ectasia. Biomedicines. 2019;7:E79.","journal-title":"Biomedicines."},{"key":"1604_CR40","doi-asserted-by":"publisher","first-page":"888","DOI":"10.4040\/jkan.2009.39.6.888","volume":"39","author":"SY Hwang","year":"2009","unstructured":"Hwang SY. Comparison of clinical manifestations and treatment-seeking behavior in younger and older patients with first-time acute coronary syndrome. J Korean Acad Nurs. 2009;39:888\u201398.","journal-title":"J Korean Acad Nurs"},{"key":"1604_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1076-7460.2001.00641.x","volume":"10","author":"G Gregoratos","year":"2001","unstructured":"Gregoratos G. Clinical manifestations of acute myocardial infarction in older patients. Am J Geriatr Cardiol. 2001;10:345\u20137.","journal-title":"Am J Geriatr Cardiol"},{"key":"1604_CR42","doi-asserted-by":"publisher","first-page":"e0174821","DOI":"10.1371\/journal.pone.0174821","volume":"12","author":"Y Li","year":"2017","unstructured":"Li Y, Lu G, Sun D, Zuo H, Wang DW, Yan J. Inhibition of endoplasmic reticulum stress signaling pathway: a new mechanism of statins to suppress the development of abdominal aortic aneurysm. PLoS One. 2017;12:e0174821.","journal-title":"PLoS One"},{"key":"1604_CR43","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","volume":"393","author":"Cholesterol Treatment Trialists\u2019 Collaboration","year":"2019","unstructured":"Cholesterol Treatment Trialists\u2019 Collaboration. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet. 2019;393:407\u201315.","journal-title":"Lancet."},{"key":"1604_CR44","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.hrtlng.2007.02.001","volume":"36","author":"M Thuresson","year":"2007","unstructured":"Thuresson M, Jarl\u00f6v MB, Lindahl B, Svensson L, Zedigh C, Herlitz J. Thoughts, actions, and factors associated with prehospital delay in patients with acute coronary syndrome. Heart Lung. 2007;36:398\u2013409.","journal-title":"Heart Lung"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01604-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-020-01604-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01604-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T19:17:41Z","timestamp":1625944661000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01604-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,11]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1604"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01604-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-21391\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-21391\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,11]]},"assertion":[{"value":"4 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethics committee of the Shanghai East Hospital, Shanghai East Hospital (Ji\u2019an Campus), and Cardiovascular Medicine of Baoshan People\u2019s Hospital of the Yunnan Province approved the study, and all patients provided written informed consent prior to participating in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"330"}}